Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy.
第一作者:
Jing,Zhang
第一单位:
Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.;Key Laboratory of Biomass Chemical Engineering of the Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.
作者:
主题词
钠米医学(Nanomedicine);多柔比星(Doxorubicin);动物(Animals);免疫疗法(Immunotherapy);人类(Humans);小鼠(Mice);投药, 口服(Administration, Oral);组蛋白脱甲基酶类(Histone Demethylases);细胞系, 肿瘤(Cell Line, Tumor);小鼠, 近交BALB C(Mice, Inbred BALB C);微胶粒(Micelles);药物协同作用(Drug Synergism);细胞增殖(Cell Proliferation);女(雌)性(Female)
DOI
10.1021/acsnano.4c14816
PMID
39612220
发布时间
2024-12-10
- 浏览0

ACS nano
33729-33742页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文